Baldness
8
1
3
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 47/100
12.5%
1 terminated out of 8 trials
80.0%
-6.5% vs benchmark
0%
0 trials in Phase 3/4
100%
4 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site)
Impact of Low-Level Laser Therapy on Hair Regrowth Post PRP Treatment
A Safety and Efficacy Study of PDFE-2304 Topical Solution for the Treatment of Androgenic Alopecia.
Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA)
A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA)
Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia
Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss
Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia